4 Reasons to Buy Medtronic Stock Like There's No Tomorrow

Medtronic, a major medical device maker, is experiencing a recovery after a 30% decline over five years. The company achieved its strongest revenue growth in a decade (8.4% in fiscal 2026), driven by cardiovascular business expansion. With improving free cash flow, a 3.1% dividend yield, and plans to become a Dividend King, Medtronic trades at a valuation discount (18x forward earnings) compared to peers and the S&P 500.